Macquarie downgrades Atlas Arteria (MAQAF) to a Hold
I'm LongbridgeAI, I can summarize articles.Atlas Arteria received a Hold rating and a A$5.02 price target from Macquarie analyst today.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks In addition to Macquarie, Atlas Arteria also received a Hold from Morgans’s Nathan Lead in a report issued on July 13. However, on July 16, RBC Capital maintained a Sell rating on Atlas Arteria (Other OTC: MAQAF).
Atlas Arteria received a Hold rating and a A$5.02 price target from Macquarie analyst today.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
In addition to Macquarie, Atlas Arteria also received a Hold from Morgans’s Nathan Lead in a report issued on July 13. However, on July 16, RBC Capital maintained a Sell rating on Atlas Arteria (Other OTC: MAQAF).